The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 16, 2007

Filed:

Sep. 17, 2004
Applicants:

Joseph Beechem, Eugene, OR (US);

Kyle Richard Gee, Springfield, OR (US);

David Carl Hagen, Eugene, OR (US);

Iain D Johnson, Eugene, OR (US);

Hee-chol Kang, Eugene, OR (US);

Christina Pastula, Seattle, WA (US);

Inventors:

Joseph Beechem, Eugene, OR (US);

Kyle Richard Gee, Springfield, OR (US);

David Carl Hagen, Eugene, OR (US);

Iain D Johnson, Eugene, OR (US);

Hee-Chol Kang, Eugene, OR (US);

Christina Pastula, Seattle, WA (US);

Assignee:

Invitrogen Corporation, Carlsbad, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/532 (2006.01); G01N 33/533 (2006.01); C12Q 1/42 (2006.01); C07K 1/13 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides ligand-detection reagents, ligand analogs and methods for determining the presence of a ligand in a sample. The ligand-detection reagent comprises a ligand-binding antibody and a ligand analog to form an antibody-ligand analog complex wherein the ligand analog is covalently bonded to a reporter molecule. This complex may additionally comprise a labeling protein non-covalently bonded to the antibody to form a ternary complex wherein the labeling protein comprises a monovalent antibody fragment or a non-antibody protein that is covalently bonded to a label moiety. The reporter molecule is either quenched by the ligand-binding antibody or by the label moiety of the labeling protein, depending on the reporter molecule and the ligand-binding antibody, wherein the amount of quenching is directly related to the amount of ligand present in the sample. Alternatively, the ligand analog is fluorogenic wherein the ligand analog is essentially non-fluorescent in solution but when bound by the ligand-binding antibody the detectable signal increases. In this instance a decrease in signal, as opposed to the relieving of quenching, is measured for the presence of a target ligand.


Find Patent Forward Citations

Quick Actions:

Beechem, Joseph. (2007). Competitive immunoassay (U.S. Patent No. 7282339). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/7282339

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…